Breast Cancer

Black Women With HR+ Breast Cancer Experience Inferior Outcomes, Despite Comparable Recurrence Scores

January 01, 2023

Non-Hispanic Black patients with hormone receptor (HR)–positive/HER2-negative breast cancer were more likely to have worse outcomes vs non-Hispanic White, Asian, and Hispanic patients, even with similar 21-gene recurrence scores.